Physicochemical Properties
| Molecular Formula | C25H23CLN4O5 |
| Molecular Weight | 494.93 |
| Exact Mass | 494.135 |
| CAS # | 2438124-79-7 |
| PubChem CID | 146628546 |
| Appearance | Light yellow to green yellow solid powder |
| LogP | 2.5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Heavy Atom Count | 35 |
| Complexity | 922 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C1(CCC(NC2=CC=C(C)C(Cl)=C2)=O)=CC=CC(NC2=CC(=O)N(C3CCC(=O)NC3=O)C2=O)=C1 |
| InChi Key | YDYSAFPHVGVORZ-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C25H23ClN4O5/c1-14-5-7-17(12-18(14)26)28-21(31)9-6-15-3-2-4-16(11-15)27-19-13-23(33)30(25(19)35)20-8-10-22(32)29-24(20)34/h2-5,7,11-13,20,27H,6,8-10H2,1H3,(H,28,31)(H,29,32,34) |
| Chemical Name | N-(3-chloro-4-methylphenyl)-3-[3-[[1-(2,6-dioxopiperidin-3-yl)-2,5-dioxopyrrol-3-yl]amino]phenyl]propanamide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Acute pharmacological degradation of Helios destabilizes regulatory T cells. Nat Chem Biol. 2021 Jun;17(6):711-717. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~50 mg/mL (~101.02 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 2.5 mg/mL (5.05 mM) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.0205 mL | 10.1024 mL | 20.2049 mL | |
| 5 mM | 0.4041 mL | 2.0205 mL | 4.0410 mL | |
| 10 mM | 0.2020 mL | 1.0102 mL | 2.0205 mL |